tesamorelin and retatrutide together π₯ The Power Duo: + When fat loss meets growth-hormone optimizationβ¦ your body levels up. β‘οΈ Retatrutide for rapid metabolic acceleration. π₯ Tesamorelin for GH-driven recovery & body recomposition. Together? Peptide & Metabolic Therapy: What
Description
The result: GLP-1 users feel less hungry, have a more muted blood sugar response after eating, and experience less mental chatter around hunger and cravingsall of which contribute to weight loss
CrossRef Triple oral therapy with metformin, DPP4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025) Miao Yu, Tong Wang, Chun Xu, Yan Bi, Ling Gao, Guang Wang, Guangda Xiang, Yaoming Xue, Tao Yang, Deying Kang, Zhiguang Zhou, Lixin Guo, Xinhua Xiao Diabetes, Obesity and Metabolism.2025
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
This one is slightly different: its a dual GIP/GLP-1 receptor agonist , not just a straight GLP-1 receptor agonist
De Lorenzo A, Gratteri S, Gualtieri P, Cammarano A, Bertucci P, Di Renzo L
Wang, J., Gao, J., Fan, Q., Li, H
